Defective Prescription Drugs We're Making a Difference.

Posts In Defective Prescription Drugs

Ranitidine in Zantac Can Trigger NDMA Formation, Causing Cancer Nov 08
Zantac and its manufacturer Sanofi are under harsh scrutiny and potentially facing a wave of lawsuits, perhaps through ...

View Article
Pharmaceutical Company Connected to NDMA Impurity Placed on Import Alert Sep 28
Active pharmaceutical ingredient (API) manufacturer Zhejiang Huahai Pharmaceuticals was placed on import alert on Friday, ...

View Article
Valsartan Voluntarily Recalled by the FDA Over NDMA Impurity Jul 19
The U.S. Food and Drug Administration (FDA) recently announced a voluntary recall of drugs that contain valsartan, an active ...

View Article
Study Shows PPIs Potentially Tied to Increased Risk of Stomach Cancer Nov 17
People suffering from Helicobacter pylori, a type of stomach bacteria that increases the risk of stomach cancer and ulcers, may ...

View Article
Trial Results Link Invokana Use to Foot and Leg Amputations May 20
According to a new trial, Invokana has shown an increased risk of leg, foot, and toe amputations. The United States Food and Drug ...

View Article
Research Shows Why PPIs Increase Risk for Heart Disease & Dementia May 16
As we have noted before, the long-term use of proton pump inhibitors has been linked to an increased risk of serious conditions ...

View Article